请输入您要查询的百科知识:

 

词条 Apararenone
释义

  1. See also

  2. References

  3. External links

{{Drugbox
| Verifiedfields =
| Watchedfields =
| verifiedrevid =
| IUPAC_name = N-[4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-1,4-benzoxazin-7-yl]methanesulfonamide
| image = Apararenone.svg
| width =
| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration = Oral
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref =
| CAS_number = 945966-46-1
| CAS_supplemental =
| class = Antimineralocorticoid
| ATC_prefix =
| ATC_suffix =
| ATC_supplemental =
| PubChem = 24744336
| IUPHAR_ligand =
| DrugBank_Ref =
| DrugBank =
| ChemSpiderID_Ref =
| ChemSpiderID = 28663572
| UNII = 832663U2NB
| KEGG =
| ChEBI =
| ChEMBL = 2181929
| C=17 | H=17 | F=1 | N=2 | O=4 | S=1
| molecular_weight = 364.391 g/mol
| SMILES = CC1(C(=O)N(C2=C(O1)C=C(C=C2)NS(=O)(=O)C)C3=CC=C(C=C3)F)C
| StdInChI_Ref =
| StdInChI = 1S/C17H17FN2O4S/c1-17(2)16(21)20(13-7-4-11(18)5-8-13)14-9-6-12(10-15(14)24-17)19-25(3,22)23/h4-10,19H,1-3H3
| StdInChIKey_Ref =
| StdInChIKey = AZNHWXAFPBYFGH-UHFFFAOYSA-N
| synonyms = MT-3995
}}Apararenone (INN) (developmental code name MT-3995) is a nonsteroidal antimineralocorticoid which is under development by Mitsubishi Tanabe Pharma for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis.[1][2][3] It was also previously being developed for the treatment of hypertension, but development was discontinued for this indication.[1] Apararenone acts as a highly selective antagonist of the mineralocorticoid receptor (Ki < 50 nM), the receptor for aldosterone.[1][2][3] As of 2017, it is in phase II clinical trials.[1]

See also

  • List of investigational hormonal agents § Mineralocorticoidics
  • Esaxerenone
  • Finerenone

References

1. ^http://adisinsight.springer.com/drugs/800032686
2. ^{{cite journal | vauthors = Yang J, Young MJ | title = Mineralocorticoid receptor antagonists-pharmacodynamics and pharmacokinetic differences | journal = Curr Opin Pharmacol | volume = 27 | issue = | pages = 78–85 | year = 2016 | pmid = 26939027 | doi = 10.1016/j.coph.2016.02.005 | url = }}
3. ^{{cite journal | vauthors = Kolkhof P, Nowack C, Eitner F | title = Nonsteroidal antagonists of the mineralocorticoid receptor | journal = Curr. Opin. Nephrol. Hypertens. | volume = 24 | issue = 5 | pages = 417–24 | year = 2015 | pmid = 26083526 | doi = 10.1097/MNH.0000000000000147 | url = }}

External links

  • Apararenone - AdisInsight
{{Mineralocorticoids and antimineralocorticoids}}{{Mineralocorticoid receptor modulators}}{{cardiovascular-drug-stub}}

6 : Antimineralocorticoids|Benzoxazines|Experimental drugs|Fluoroarenes|Ketones|Sulfonamides

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/22 18:16:06